Available Trials

Hematologic

  • Large B-CELL Lymphoma

    ROBUST trial – Phase III Randomized, Double-Blind, Placebo Controlled, Multi-center Study to Compare the Efficacy and Safety of Lenalidomide (CC-5013) Plus R-CHOP Chemotherapy (R2-CHOP) Versus Placebo Plus R-CHOP Chemotherapy in Subjects with Previously Untreated, Non-Germinal Center Type Diffuse Large B-cell Lymphoma

    Available at 6 locations

  • MDS/AML OBSERVATIONAL STUDY

    Connect MDS and AML Disease registry

    Available at 6 locations

  • CLL UNITY trial

    A Phase 3, Randomized Study to Assess the Efficacy and Safety of Ublituximab in Combination with TGR-1202 Compared to Obinutuzumab in Combination with Chlorambucil in Patients with Chronic Lymphocytic Leukemia.

    Available at 6 locations

  • CLL – ACE-CL-006

    A Randomized, Multicenter, Open-Label, Non-Inferiority, Phase 3 Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects with High Risk Chronic Lymphocytic Leukemia

    Available at 6 locations